share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Trizzino John

諾瓦瓦克斯醫藥 | 4:持股變動聲明-高管 Trizzino John
美股SEC公告 ·  08/21 16:50
Moomoo AI 已提取核心訊息
On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 655 shares at no cost, and subsequently sold 317 shares at a price of $13.9 per share. Following these transactions, Trizzino's direct holdings in Novavax amounted to 28,310 shares. The total market value of the disposed shares was $4,406.3.
On August 19, 2024, John Trizzino, EVP, CCO, and CBO of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. Trizzino exercised options to acquire 655 shares at no cost, and subsequently sold 317 shares at a price of $13.9 per share. Following these transactions, Trizzino's direct holdings in Novavax amounted to 28,310 shares. The total market value of the disposed shares was $4,406.3.
2024年8月19日,諾瓦瓦克斯醫藥公司(NVAX)的執行副總裁兼首席商業官John Trizzino完成了一筆涉及公司普通股的股票交易。Trizzino行使期權以無成本獲得655股股票,隨後以每股13.9美元的價格出售了317股。在這些交易之後,Trizzino在諾瓦瓦克斯醫藥公司的直接持股達到28,310股。出售股票的總市值爲4,406.3美元。
2024年8月19日,諾瓦瓦克斯醫藥公司(NVAX)的執行副總裁兼首席商業官John Trizzino完成了一筆涉及公司普通股的股票交易。Trizzino行使期權以無成本獲得655股股票,隨後以每股13.9美元的價格出售了317股。在這些交易之後,Trizzino在諾瓦瓦克斯醫藥公司的直接持股達到28,310股。出售股票的總市值爲4,406.3美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息